Solar Urticaria


Article Author:
Talel Badri


Article Editor:
Joel Schlessinger


Editors In Chief:
Ahmad Al Aboud
Jayakar Thomas
Pramod Nigam


Managing Editors:
Avais Raja
Orawan Chaigasame
Carrie Smith
Abdul Waheed
Khalid Alsayouri
Kyle Blair
Trevor Nezwek
Radia Jamil
Erin Hughes
Patrick Le
Anoosh Zafar Gondal
Saad Nazir
William Gossman
Hassam Zulfiqar
Navid Mahabadi
Hussain Sajjad
Steve Bhimji
Muhammad Hashmi
John Shell
Matthew Varacallo
Heba Mahdy
Ahmad Malik
Abbey Smiley
Sarosh Vaqar
Mark Pellegrini
James Hughes
Beata Beatty
Daniyal Ameen
Altif Muneeb
Beenish Sohail
Nazia Sadiq
Hajira Basit
Phillip Hynes
Komal Shaheen
Sandeep Sekhon


Updated:
4/11/2019 11:12:24 PM

Introduction

Solar urticaria is a chronic acquired photosensitivity disorder. It consists of recurrent episodes of urticaria rash developed on areas of the skin that are exposed to sunlight. Despite being usually a benign condition, it may be extremely disabling, thus limiting everyday activities and severely altering the quality of life of patients.[1][2][3][4]

Etiology

Exposure of skin to sunlight causes sSolar urticaria. The radiation spectrum of action for solar urticaria ranges from ultraviolet B to visible light (wavelength of 300 nanometers to 500 nanometers) and is variable from one patient to another.[5]

Epidemiology

Solar urticaria is an uncommon type of urticaria. It accounts for less than 0.5% of all urticaria cases and 7% of all photodermatoses. The disease usually begins in young adulthood (median age 35 years), but cases of onset in neonates or elderly persons have been reported. There is a female predominance but no ethnicity difference. In the largest series of patients, a history of atopy is noticed in less than 30% of cases. The association of solar urticaria with other types of chronic urticaria may be seen in up to 16% of patients.[6][7]

Pathophysiology

Solar urticaria pathophysiology is not entirely understood. It is an immediate hypersensitivity reaction, which might be IgE-mediated, occurring after exposure to the sun. The radiation may activate an endogenous substance called chromophore which could be present in the serum and/or the dermis, turning it into an immunologically active photo allergen. This later induces the degranulation of mast cells, resulting in lesions of urticaria. The intradermal positive reaction after injection of patient’s irradiated serum is consistent with the hypothesis of a circulating chromophore.

Certain radiation wavelengths (usually long ones) may inhibit the immunological reaction induced by other wavelengths (usually short ones). This is called the double spectrum of action.

Occasionally, solar urticaria is triggered by an exogenous substance, such as some medications such as atorvastatin, chlorpromazine, tetracycline, or oral contraceptives.[8][9][10]

History and Physical

Erythema and edematous papules occur, within a few minutes after exposure to sunlight, on sun-exposed areas, and even on areas covered with thin and white clothing that allows the solar radiation to reach the underlying skin. Usually, covered skin reacts more severely to the sun when it is exposed. The face and hand skin seems more tolerant to sun radiation. The rash is associated with a sensation of itching or burning. Periorbital and/or mucosal angioedema may also be observed. Dermographism may be noticed in some patients. Systemic symptoms such as nausea, wheezing, dyspnea, or syncope are not uncommon, especially if large areas of the skin are exposed to sunlight during a long period. However, even if systemic symptoms are present, anaphylactic shock rarely occurs in solar urticaria. The cutaneous symptoms resolve in 75% of cases within an hour following the interruption of sun exposure and more within 24 hours. The severity and the duration of the symptoms are also related to the intensity of light.

Evaluation

The diagnosis of solar urticaria is suspected on anamnesis (transient urticarial lesions occurring a few minutes after exposure to sunlight), while the physical examination is normal in the absence of sun exposure.

Symptoms and distribution of solar urticaria can mimic other acquired photodermatoses. Differential diagnosis includes polymorphous light eruption, lupus erythematosus, drug-induced photosensitivity, and photo contact dermatitis. However, solar urticaria may be associated with other photodermatoses, such as polymorphous light eruption and porphyria cutanea tarda.

The diagnosis of solar urticaria is confirmed by photo testing using UVA, UVB, and visible light sources. Sometimes natural light is also used. The aim of photo testing is to determine the spectrum of action (the triggering wavelengths) and the minimal urticarial dose (the minimal dose inducing an urticarial reaction). Determining the spectrum of action is also important for subsequent management so that the patients take precaution to avoid the triggering wavelengths.

The light sources are placed 10 centimeters to 15 centimeters from the back of the patient, and different doses of radiations are delivered. Clinical response is assessed every 10 minutes for an hour. Erythema and wheal occur immediately after photo testing and fade a few minutes after radiation cessation. However, in many cases, photo testing with artificial light sources is not contributive, as it may fail to induce cutaneous lesions, which may be triggered only by natural sunlight exposure. In some cases, repeating photo testing may help to obtain positive results.

A histopathological examination may be performed to rule out other photodermatoses. In solar urticaria, it shows typical features of urticaria which are endothelial swelling and dermal neutrophil, monocyte, and eosinophil infiltration.

Photopatch testing may be beneficial to rule out a drug-induced photosensitivity or a photo contact dermatitis.

Treatment / Management

There are no guidelines for the treatment of solar urticaria. Different treatments have been used with variable success. Sun exposure avoidance is logically recommended, as well as the use of broad-spectrum sunscreens and dark clothing photoprotection.[11][12][13]

By analogy with idiopathic chronic urticaria treatment, antihistamine one receptor agents are largely used. They may induce a relief in most cases but usually at higher doses, two to four times higher than the conventional ones. Antihistamine 1 receptor agents seem to have greater efficacy in delayed onset urticaria, but no effect on the erythema in solar urticaria.

Since chronically exposed areas seem relatively tolerant to sun radiations, phototherapy (UVA, UVB, visible light), and photochemotherapy (PUVA) have been used to induce tolerance (hardening) to sunlight. This hardening process should be based on the spectrum of action and the minimal urticarial dose. PUVA seems to give a longer-lived response than phototherapy alone.

Intravenous immunoglobulins, plasma exchange, cyclosporine, afamelanotide, and omalizumab have been used in patients with refractory solar urticaria with some success.

Oral steroids, leukotriene receptor antagonists, antimalarial drugs, prostaglandin inhibitors, and oral beta-carotene, have shown little or no effect in the management of solar urticaria. Combination therapies are frequently needed to achieve and maintain acceptable clinical relief.

Pearls and Other Issues

Solar urticaria often has a chronic course. Approximately the half of patients continue to be symptomatic ten to 15 years after the disease onset. A longer duration of solar urticaria before the first medical evaluation, as well as an age older than 40 years, are associated with a longer disease course. Patients with exclusive reactivity to visible or natural light seem to have the best prognosis.

Enhancing Healthcare Team Outcomes

Solar urticaria is a enigmatic disorder which is not well understood. while the diagnosis is simple, its management is difficult. The condition is often encountered by the primary care provider, nurse practitioner, dermatologist and internist. However, because the condition can be difficult to distinguish from other itching disorders a referral to a dermatologist is recommended.

There are no guidelines for the treatment of solar urticaria. Different treatments have been used with variable success. Sun exposure avoidance is logically recommended, as well as the use of broad-spectrum sunscreens and dark clothing photoprotection.

Those who fail conservative treatment may be managed with photoherapy and biological agents. Overall, the prognosis for patients with severe urticaria is poor. Many patients are restricted indoors and lead a poor quality of life.[14] (Level V)

 

 


  • Image 5648 Not availableImage 5648 Not available
    Contributed by Talel Badri
Attributed To: Contributed by Talel Badri

Interested in Participating?

We are looking for contributors to author, edit, and peer review our vast library of review articles and multiple choice questions. In as little as 2-3 hours you can make a significant contribution to your specialty. In return for a small amount of your time, you will receive free access to all content and you will be published as an author or editor in eBooks, apps, online CME/CE activities, and an online Learning Management System for students, teachers, and program directors that allows access to review materials in over 500 specialties.

Improve Content - Become an Author or Editor

This is an academic project designed to provide inexpensive peer-reviewed Apps, eBooks, and very soon an online CME/CE system to help students identify weaknesses and improve knowledge. We would like you to consider being an author or editor. Please click here to learn more. Thank you for you for your interest, the StatPearls Publishing Editorial Team.

Solar Urticaria - Questions

Take a quiz of the questions on this article.

Take Quiz
A 32-year-old female patient, with no remarkable medical history, presents with a six-month history of a recurrent, itching rash of the face. Which statement is not consistent with the diagnosis of solar urticaria in this patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 48-year-old male patient with no remarkable medical history presents with erythema and wheals that occur shortly after sun exposure. How would one establish the positive diagnosis of solar urticaria in this patient?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
A 29-year-old female patient presents with a two-year history of solar urticaria which is resistant to several antihistamines. A "hardening" is decided. Which is correct?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which range of light is not usually used during photo testing in solar urticaria?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up
Which of the following is not an effective treatment for solar urticaria?



Click Your Answer Below


Would you like to access teaching points and more information on this topic?

Improve Content - Become an Author or Editor and get free access to the entire database, free eBooks, as well as free CME/CE as it becomes available. If interested, please click on "Sign Up" to register.

Purchase- Want immediate access to questions, answers, and teaching points? They can be purchased above at Apps and eBooks.


Sign Up

Solar Urticaria - References

References

Milanesi N,Gola M,Francalanci S, Evaluation of nine patients with solar urticaria during summer. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 2019 Mar 29;     [PubMed]
Snast I,Lapidoth M,Uvaidov V,Enk CD,Mazor S,Hodak E,Levi A, Real-life experience in the treatment of solar urticaria: retrospective cohort study. Clinical and experimental dermatology. 2019 Mar 3;     [PubMed]
Photiou L,Foley P,Ross G, Solar urticaria - An Australian case series of 83 patients. The Australasian journal of dermatology. 2018 Dec 25;     [PubMed]
Lyons AB,Peacock A,Zubair R,Hamzavi IH,Lim HW, Successful treatment of solar urticaria with UVA1 hardening in three patients. Photodermatology, photoimmunology     [PubMed]
Snyder M,Turrentine JE,Cruz PD Jr, Photocontact Dermatitis and Its Clinical Mimics: an Overview for the Allergist. Clinical reviews in allergy     [PubMed]
Fityan A,McGibbon D,Fassihi H,Sarkany RS, Paediatric solar urticaria: a case series. The British journal of dermatology. 2018 Jun;     [PubMed]
Raigosa M,Toro Y,Sánchez J, [Solar urticaria. Case report and literature review]. Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993). 2017 Jul-Sep;     [PubMed]
Griffin LL,Haylett AK,Rhodes LE, Evaluating patient responses to omalizumab in solar urticaria. Photodermatology, photoimmunology     [PubMed]
Chicharro P,Rodríguez-Jiménez P,Capusan TM,Herrero-Moyano M,de Argila D, Induction of Light Tolerance Using Narrowband UV-B in Solar Urticaria. Actas dermo-sifiliograficas. 2018 Dec;     [PubMed]
Farr PM, Erythropoietic protoporphyria and solar urticaria. The British journal of dermatology. 2018 Aug;     [PubMed]
Maurer M,Fluhr JW,Khan DA, How to Approach Chronic Inducible Urticaria. The journal of allergy and clinical immunology. In practice. 2018 Jul - Aug;     [PubMed]
Snast I,Kremer N,Lapidoth M,Enk CD,Tal Y,Rosman Y,Confino-Cohen R,Hodak E,Levi A, Omalizumab for the Treatment of Solar Urticaria: Case Series and Systematic Review of the Literature. The journal of allergy and clinical immunology. In practice. 2018 Jul - Aug;     [PubMed]
Morgado-Carrasco D,Fustà-Novell X,Podlipnik S,Combalia A,Aguilera P, Clinical and photobiological response in eight patients with solar urticaria under treatment with omalizumab, and review of the literature. Photodermatology, photoimmunology     [PubMed]
Haylett AK,Koumaki D,Rhodes LE, Solar urticaria in 145 patients: Assessment of action spectra and impact on quality of life in adults and children. Photodermatology, photoimmunology     [PubMed]

Disclaimer

The intent of StatPearls is to provide practice questions and explanations to assist you in identifying and resolving knowledge deficits. These questions and explanations are not intended to be a source of the knowledge base of all of medicine, nor is it intended to be a board or certification review of Dermatology-Pediatric. The authors or editors do not warrant the information is complete or accurate. The reader is encouraged to verify each answer and explanation in several references. All drug indications and dosages should be verified before administration.

StatPearls offers the most comprehensive database of free multiple-choice questions with explanations and short review chapters ever developed. This system helps physicians, medical students, dentists, nurses, pharmacists, and allied health professionals identify education deficits and learn new concepts. StatPearls is not a board or certification review system for Dermatology-Pediatric, it is a learning system that you can use to help improve your knowledge base of medicine for life-long learning. StatPearls will help you identify your weaknesses so that when you are ready to study for a board or certification exam in Dermatology-Pediatric, you will already be prepared.

Our content is updated continuously through a multi-step peer review process that will help you be prepared and review for a thorough knowledge of Dermatology-Pediatric. When it is time for the Dermatology-Pediatric board and certification exam, you will already be ready. Besides online study quizzes, we also publish our peer-reviewed content in eBooks and mobile Apps. We also offer inexpensive CME/CE, so our content can be used to attain education credits while you study Dermatology-Pediatric.